11:48 AM EDT, 05/02/2024 (MT Newswires) -- Enovis ( ENOV ) shares were down more than 6% in recent Thursday trading after the company reported Q1 adjusted earnings Thursday of $0.50 per diluted share, up from $0.44 a year earlier.

Analysts polled by Capital IQ expected $0.48.

Net sales for the quarter ended March 29 was $516.3 million, up from $406.2 million a year earlier.

Analysts surveyed by Capital IQ expected $505.6 million.

For 2024, the medical technology firm is now projecting non-GAAP EPS of $2.52 to $2.67 on revenue of $2.06 billion to $2.16 billion, up $0.02 per share and $10 million, respectively, over its prior forecast.

Analysts polled by Capital IQ are looking for adjusted earnings of $2.60 per share and $2.12 billion in revenue this year.

Price: 51.93, Change: -3.47, Percent Change: -6.26